¹H-MRS of hippocampus in patients after first manic episode

References

• al-Mousawi AH, Evans N, Ebmeier KP, Roeda D, Chaloner F, Ashcroft GW. 1996. Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography. Br J Psychiatry 169(4): 509–516.
   Google Scholar
• American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: APA.
   Google Scholar
• Atmaca M, Yildirim H, Ozdemir H, Poyraz AK, Tezcan E, Ogur E. 2006. Hippocampal 1H MRS in first-episode bipolar I patients. Prog Neuropsychopharmacol Biol Psychiatry 30:1235–1239.
   PubMedGoogle Scholar
• Atmaca M, Yildirim H. 2012. Altered neurochemical Ingredient of Hippocampus in Patients with bipolar Depression. Depress Res Treat. doi:10.1155/2012/485249.
   Google Scholar
• Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. 1998. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44(2):88–97.
   Google Scholar
• Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF. 2001. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 49(1):39–46.
   Google Scholar
• Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, et al. 2003. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 53:906–913.
   PubMed Web of Science ®Google Scholar
• Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, et al. 2005. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 86(1):61–67.
   Google Scholar
• Chang K, Adleman N, Dienes K, Barnea-Goraly N, Reiss A, Ketter T. 2003. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry 53(11):1059–1065.
   Google Scholar
• Colla M, Schubert F, Bubner M, Heidenreich J, Bajbouj M, Seifert F, et al. 2009. Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol. Mol Psychiatry 14(7):696–704.
   Google Scholar
• Curtis VA, Dixon TA, Morris RG, Bullmore ET, Brammer MJ, Williams SC, et al. 2001. Differential frontal activation in schizophrenia and bipolar illness during verbal fluency. J Affect Disord 66(2–3):111–121.
   Google Scholar
• Daban C, Vieta E, Mackin P, Young A. 2005. Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am 28(2):469–480.
   Google Scholar
• Davanzo P, Yue K, Thomas M, Belin T, Mintz J, Venkatraman T, et al. 2003. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am J Psychiatry 160(8):1442–1452.
   Google Scholar
• Deicken RF, Pegues MP, Anzalone S, Feiwell R, Soher B. 2003. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 160:873–882.
   PubMed Web of Science ®Google Scholar
• DelBello MP, Cecil KM, Adler CM, Daniels JP, Strakowski SM. 2006. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology 31(6):1264–1273.
   Google Scholar
• Forester BP, Finn CT, Berlow YA, Wardrop M, Renshaw PF, Moore CM. 2008. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study. Bipolar Disord 10(6):691–700.
   Google Scholar
• Frye MA, Watzl J, Banakar S, O’Neill J, Mintz J, Davanzo P, et al. 2007. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 32(12):2490–2499.
   Google Scholar
• Gigante AD, Young LT, Yatham LN, Andreazza AC, Nery FG, Grinberg LT, et al. 2011. Morphometric post- mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 14(8):1075–1089.
   Google Scholar
• Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN. 2012. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 14(5):478–487.
   Google Scholar
• Guy W. 1976. Clinical Global Impressions. In: Guy W, editor. ECDEU assessment manual for psychopharmacology. Revised. Rockville, MD: National Institute of Mental Health.
   Google Scholar
• Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE, et al. 2011. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega- analysis of individual adult patient data. Biol Psychiatry 69: 326–335.
   PubMed Web of Science ®Google Scholar
• Hamakawa H, Kato T, Murashita J, Kato N. 1998. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 248(1):53–58.
   Google Scholar
• Iosifescu DV, Moore CM, Deckersbach T, Tilley CA, Ostacher MJ, Sachs GS, et al. 2009. Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study. CNS Neurosci Ther 15:309–319.
   PubMedGoogle Scholar
• Kapczinski F, Frey BN, Kauer-Sant’Anna M, Grassi-Oliveira R. 2008. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 8(7):1101–1113.
   PubMedGoogle Scholar
• Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant’Anna M, Klamt F, et al. 2010. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry 15(8):784–786.
   Google Scholar
• Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, et al. 1996. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 21(4):248–254.
   Google Scholar
• Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, et al. 2009. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 12(4):447–458.
   Google Scholar
• Kay SR, Fiszbein A, Opler LA. 1987. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276.
   PubMed Web of Science ®Google Scholar
• Ketter T A, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE, et al. 2001. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 49(2):97–109.
   Google Scholar
• Kim YK, Jung HG, Myint AM, Kim H, Park SH. 2007. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 104(1–3):91–95.
   Google Scholar
• Kreis R. 2004. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 17:361–381.
   PubMed Web of Science ®Google Scholar
• Kunz M, Gama CS, Andreazza AC, Salvador M, Ceresér KM, Gomes FA, et al. 2008. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32(7):1677–1681.
   Google Scholar
• Lafer, B, Renshaw PF, Sachs G, Christensen JD, Yurgelun-Todd D, Stoll AL, et al. 1994. Proton MRS of the basal ganglia in bipolar disorder. Biol Psychiatry 35:685.
   Google Scholar
• Lagopoulos J, Malhi GS. 2007. A functional magnetic resonance imaging study of emotional Stroop in euthymic bipolar disorder. Neuroreport 18:1583–1587.
   Google Scholar
• Liu L, Schulz SC, Lee S, Reutiman TJ, Fatemi SH. 2007. Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cell Mol Neurobiol 27:351–358.
   PubMedGoogle Scholar
• Lyoo K, Renshaw PF. 2010. Functional magnetic resonance imaging, diffusion tensor imaging, and magnetic resonance spectroscopy in bipolar disorder. In: Yatham LN, Maj M, editors. Bipolar disorder – clinical and neurobiological foundations. Oxford: Wiley-Blackwell. p. 133–199.
   Google Scholar
• Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V Jr, da Silva Vargas R, et al. 2007. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 421:33–36.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Lagopoulos J, Owen AM, Ivanovski B, Shnier R, Sachdev P. 2007a. Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. J Affect Disord 97:109–122.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Ivanovski B, Wen W, Lagopoulos J, Moss K, Sachdev P. 2007b. Measuring mania metabolites: a longitudinal proton spectroscopy study of hypomania. Acta Psychiatr Scand Suppl 434:57–66.
   Google Scholar
• Moghaddam B. 1993. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 60(5):1650–1657.
   Google Scholar
• Moore CM, Breeze JL, Gruber SA, Babb SM, Frederick BB, Villafuerte RA, et al. 2000. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2(3 Pt 2):207–216.
   Google Scholar
• Moore GJ, Bebchuk JM, Parrish JK, Faulk MW, Arfken CL, Strahl-Bevacqua J, et al. 1999. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 156:1902–1908.
   PubMed Web of Science ®Google Scholar
• Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB. 2000. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?Biol Psychiatry 48(1):1–8.
   Google Scholar
• Nery FG, Stanley JA, Chen HH, Hatch JP, Nicoletti MA, Monkul ES. 2010. Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study. J Psychiatr Res 44(5):278–285.
   Google Scholar
• Ng WX, Lau IY, Graham S, Sim K. 2009. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis. Neurosci Biobehav Rev 33:336–354.
   PubMed Web of Science ®Google Scholar
• Olvera RL, Caetano SC, Fonseca M, Nicoletti M, Stanley JA, Chen HH. 2007. Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. J Child Adolesc Psychopharmacol 17(4):461–473.
   Google Scholar
• Overall JE, Gorham DR. 1962. The Brief Psychiatric Rating Scale. Psychol Rep 10:799–812.
   Web of Science ®Google Scholar
• Patel NC, DelBello MP, Cecil KM, Stanford KE, Adler CM, Strakowski SM. 2008. Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium. J Child Adolesc Psychopharmacol 18(2): 132–139.
   Google Scholar
• Pavuluri MN, O’Connor MM, Harral E, Sweeney JA. 2007. Affective neural circuitry during facial emotion processing in pediatric bipolar disorder. Biol Psychiatry 62:158–167.
   PubMed Web of Science ®Google Scholar
• Provencher SW. 1993. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679.
   PubMed Web of Science ®Google Scholar
• Rao JS, Harry GJ, Rapoport SI, Kim HW. 2010. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15(4):384–392.
   Google Scholar
• Scherk H, Backens M, Schneider-Axmann T, Kemmer C, Usher J, Reith W, et al. 2008. Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder. Acta Psychiatr Scand 117:283–288.
   Google Scholar
• Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ. 1995. Combined dexamethasone/corticotropin- releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol Psychiatry 38(12):797–802.
   Google Scholar
• Schubert MI, Kalisch R, Sotiropoulos I, Catania C, Sousa N, Almeida OF, et al. 2008. Effects of altered corticosteroid milieu on rat hippocampal neurochemistry and structure – an in vivo magnetic resonance spectroscopy and imaging study. J Psychiatr Res 42(11):902–912.
   Google Scholar
• Senaratne R, Milne A, MacQueen G, Hall G. 2009. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res 172:205–209.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33.
   PubMed Web of Science ®Google Scholar
• Silverstone PH, Wu RH, O’Donnell T, Ulrich M, Asghar SJ, Hanstock CC. 2003. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol (2):73–79.
   Google Scholar
• Soares JC, Mann JJ. 1997. The anatomy of mood disorders – review of structural neuroimaging studies. Biol Psychiatry 41(1):86–106.
   Google Scholar
• Strakowski SM, DelBello MP, Adler CM. 2005. The functional neuroanatomy of bipolar disorder. A review of neuroimaging findings. Mol Psychiatry 10:105–116.
   PubMed Web of Science ®Google Scholar
• Strakowski SM, Adler CM, Almeida J, Altshuler LL, Blumberg HP, Chang KD, et al. 2012. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord 14(4):313–325.
   Google Scholar
• Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH. 2004. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 184:496–502.
   PubMed Web of Science ®Google Scholar
• Williams JBW, Link MJ, Rosenthal NE, Terman M. 1988. Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGH-SAD). New York: New York State Psychiatric Institute.
   Google Scholar
• Yatham LN, Kauer-Sant’Anna M, Bond DJ, Lam RW, Torres I. 2009. Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project. Can J Psychiatry 54(2):105–112.
   Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435.
   PubMed Web of Science ®Google Scholar
• Zarate CJ, Singh J, Manji H. 2006. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59:1006–1020.
   PubMed Web of Science ®Google Scholar